Adaptive immune response in women from the Russian Arctic region after COVID-19 infection
- 作者: Shashkova E.Y.1, Shchegoleva L.S.1, Filippova O.E.1, Popovskaya E.V.1, Sergeeva T.B.1
-
隶属关系:
- N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
- 期: 卷 30, 编号 11 (2023)
- 页面: 857-863
- 栏目: ORIGINAL STUDY ARTICLES
- URL: https://journals.rcsi.science/1728-0869/article/view/257881
- DOI: https://doi.org/10.17816/humeco624207
- ID: 257881
如何引用文章
全文:
详细
BACKGROUND: The Arctic region of Russia is characterized by disproportionately high rates of morbidity and mortality from COVID-19 during the pandemic. The harsh climatic and environmental conditions in this area impede the development of self-regulation processes resulting in activation and strain of both cellular and humoral immunity. This leads to a depletion of the body’s reserve capacities. At present, there is lack of research examining how individuals who have recovered from COVID-19 are affected by the extreme conditions of Arctic Russia.
AIM: To study the ratio of immunocompetent cells involved in the adaptive immune response following COVID-19 infection.
MATERIAL AND METHODS: A total of 29 women aged 20 – 40 years were examined in Arkhangelsk as part of a comprehensive immunological study. This study involved assessment of the number of leukocytes, lymphocytes, and their phenotypes (CD5+, CD8+, CD10+, CD95+), as well as determination of phagocytic activity and phagocytic number.
RESULTS: The cellular adaptive immune response in observed individuals 6 months after experiencing moderate COVID-19 disease was characterized by a very low concentration of T cells (CD5+) in all cases, CD10+ lymphocytes (44.83%) alongside with a high concentration of cytotoxic lymphocytes (CD8+) in 48.27% of individuals and lymphocytes with receptors for apoptosis (CD95+) in 51.72%, with relatively high phagocytic activity ranging from 90 to 100%. A correlation was found in 11.29% of women between the low content of CD10+ and CD95+ cells with the activity of phagocytosis. In 40% of women with high phagocytic activity, the concentrations of cytotoxic cells (CD8+) were found to be at a minimum level.
CONCLUSIONS: Women with high phagocytic activity were found to have the lowest concentrations of cytotoxic cells, suggesting a potentially positive prognosis for reducing the risk of complications. This indicates that cellular immunity may play a role in determining the severity of COVID-19 infection in individuals with high phagocytic activity.
作者简介
E. Shashkova
N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
编辑信件的主要联系方式.
Email: eli1255@ya.ru
ORCID iD: 0000-0002-1735-6690
SPIN 代码: 8137-0571
Cand. Sci. (Biology)
俄罗斯联邦, 249 Lomonosov ave., Arkhangelsk, 163000L. Shchegoleva
N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
Email: shchegoleva60@mail.ru
ORCID iD: 0000-0003-4900-4021
SPIN 代码: 6859-2123
Dr. Sci. (Biology), Professor
俄罗斯联邦, ArkhangelskO. Filippova
N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
Email: eli1255@ya.ru
ORCID iD: 0000-0001-6117-0562
SPIN 代码: 8507-7525
Cand. Sci. (Biology)
俄罗斯联邦, ArkhangelskE. Popovskaya
N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
Email: miakati15@gmail.com
ORCID iD: 0000-0002-6306-1068
SPIN 代码: 4890-4668
俄罗斯联邦, Arkhangelsk
T. Sergeeva
N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Science
Email: tanya--86@mail.ru
ORCID iD: 0000-0003-0745-3099
SPIN 代码: 6139-1758
Cand. Sci. (Biology)
俄罗斯联邦, Arkhangelsk参考
- Hathaway ED. American Indian and Alaska native people: Social vulnerability and COVID-19. The Journal of Rural Health. 2021;37(1):256–259. doi: 10.1111/jrh.12505
- Donaldson S, Adlard B, Odland JØ. Overview of human health in the Arctic: conclusions and recommendations. International Journal of Circumpolar Health. 2016;75:33807. doi: 10.3402/ijch.v75.33807
- Akimkin VG, Popova AY, Ploskireva АА, et al. COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process. Journal of Microbiology, Epidemiology and Immunobiology. 2022;99(3):269–286. EDN: ZXGTFD doi: 10.36233/0372-9311-276
- Troshina EA, Melnichenko GA, Senyushkina ES, Mokryshe- va NG. Adaptation of the hypothalamo-pituitary-thyroid and hypothalamo-pituitary-adrenal systems to a new infectious disease — COVID-19 in the development of COVID-19 pneumonia and/or cytokine storm. Clinical and Experimental Thyroidology. 2020;16(1):21–27. EDN: ISXSTK doi: 10.14341/ket12461
- Kaufmann SH, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nature Reviews Drug Discovery. 2018;17(1):35–56. doi: 10.1038/nrd.2017.162
- Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pacific Journal of Allergy and Immunology. 2020;38(1):10–18. doi: 10.12932/AP-200220-0773
- Knyazev S, Chhugani K, Sarwal V, et al. Unlocking capacities of genomics for the COVID-19 response and future pandemics. Nature Methods. 2022;19(4):374–380. doi: 10.1038/s41592-022-01444-z
- Van Damme W, Dahake R, Delamou A, et al. The COVID-19 pandemic: diverse contexts; different epidemics — how and why? BMJ Global Health. 2020;5(7):e003098. doi: 10.1136/bmjgh-2020-003098
- Smirnov VS, Totolyan AA. Innate immunity during coronavirus infection. Russian Journal of Infection and Immunity. 2020;10(2): 259–268. EDN: WZIDLN doi: 10.15789/2220-7619-III-1440
- Toptygina AP, Semikina EL, Zakirov RSh, Afridonova ZE. Comparison of the humoral and cellular immunity in COVID-19 convalescents. Russian Journal of Infection and Immunity. 2022;12(3):495–504. EDN: UJQPUV doi: 10.15789/2220-7619-COT-1809
- Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. doi: 10.1126/science.abf4063
- Stephens DS, McElrath MJ. COVID-19 and the path to immunity. Jama. 2020;324(13):1279–1281. doi: 10.1001/jama.2020.16656
- Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489–1501. doi: 10.1016/j.cell.2020.05.015
- Alotaibi F, Rytelewski M, Figueredo R, et al. CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity. European Journal of Immunology. 2020;50(5):695–704. doi: 10.1002/eji.201948309
- Freitas CMT, Johnson DK, Weber KS. T cell calcium signaling regulation by the co-receptor CD5. International Journal of Molecular Sciences. 2018;19(5):1295. doi: 10.3390/ijms19051295
补充文件
